News

Helen of Troy Limited Adjusts Earnings Call Schedule

Helen of Troy Limited Adjusts Earnings Call Schedule

Helen of Troy Limited Adjusts Earnings Release Date

In a significant move, Helen of Troy Limited (NASDAQ: HELE), a premier designer and marketer of branded home, outdoor, beauty, and wellness products, announced a revised schedule for its third quarter fiscal 2025 earnings release. The new date is set for January 8, 2025, before the stock market opens. This adjustment was made to respect the National Day of Mourning following the passing of former President Jimmy Carter.

Details of the Earnings Release

The initial announcement for the earnings release was slated for January 9, 2025. However, the company has altered this plan to align with the observance of this solemn occasion. By conducting their earnings call on January 8, Helen of Troy Limited demonstrates its dedication to honoring significant national moments while maintaining transparency with its investors.

Conference Call Information

Following the earnings release, Helen of Troy will host a conference call at 9:00 a.m. Eastern Time on the same day. This call will feature the company's key leaders, including Noel Geoffroy, CEO; Brian Grass, CFO; and Sabrina McKee Budd, Senior VP of Business Development and Investor Relations, who will discuss the financial results and answer questions from analysts and institutional investors.

How to Participate

Interested parties are encouraged to join the call by dialing (877) 407-3982 approximately ten minutes beforehand to ensure they can participate. Additionally, the conference call will be accessible via live webcast on the company’s Events & Presentations page. This hybrid format ensures that all stakeholders have the opportunity to stay informed about the company's performance and strategic direction.

Replay Information

For those unable to attend the live call, a telephone replay will be available from 1:00 p.m. Eastern Time on January 8 until 11:59 p.m. on January 22. Participants can listen to the replay by calling (844) 512-2921 and entering the replay pin number 13750606. The webcast replay will also remain available on the website for one year, allowing investors and interested parties to catch up on any missed information.

Understanding Helen of Troy Limited

Helen of Troy Limited is recognized for its commitment to providing innovative consumer products that enhance lives. Operating under various brand names such as OXO, Hydro Flask, and Vicks, Helen of Troy Limited (NASDAQ: HELE) leverages its diverse portfolio to offer quality solutions to customers worldwide. The company’s dedication to excellence and reliability has established it as a trusted name in various market segments, which continues to bolster its enduring success.

Legacy and Focus on Community Engagement

As a company rooted in community engagement, Helen of Troy Limited emphasizes the importance of social responsibility. By choosing to alter its earnings release schedule to honor the legacy of a notable figure like former President Jimmy Carter, Helen of Troy showcases its commitment to honoring moments of significance intertwined with national pride. The company's actions reflect a deep understanding of its role not only as a business but as a contributing member of society.

Continuous Growth and Innovation

With a diversified portfolio, Helen of Troy Limited remains focused on growth and fostering innovation in all its product lines. The company is steadfast in improving its offerings and serving its customer base effectively. Whether through advancements in technology or enhancing product features, Helen of Troy is dedicated to understanding consumer needs and adapting accordingly.

For more information on Hydro Flask visit the company website here: https://www.hydroflask.com/

Frequently Asked Questions

What changes did Helen of Troy Limited announce regarding its earnings release?

Helen of Troy Limited rescheduled its third quarter fiscal 2025 earnings release to January 8, 2025, in observance of the National Day of Mourning.

Who will host the conference call for the earnings release?

The conference call will be hosted by CEO Noel Geoffroy, CFO Brian Grass, and SVP Sabrina McKee Budd.

How can investors participate in the earnings call?

Investors can join the call by dialing (877) 407-3982 approximately ten minutes before it starts.

Is there a way to replay the conference call?

Yes, a replay will be available by calling (844) 512-2921 and using the pin number 13750606. Additionally, a webcast replay will be available for one year.

What brands does Helen of Troy Limited offer?

Helen of Troy Limited offers a range of products under brands such as OXO, Hydro Flask, Vicks, and many others, focusing on quality and innovation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading